Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is now a common cause of cancer death, with no obvious change in patient survival over the past few years. Although the traditional therapeutic modalities for HCC patients mainly involved in surgery, chemotherapy, and radiotherapy, which have achieved admirable achieve...
Saved in:
Main Authors: | Shijing Yu (Author), Ruirui Zhao (Author), Bingchen Zhang (Author), Chunmei Lai (Author), Linyan Li (Author), Jiangwen Shen (Author), Xiarong Tan (Author), Jingwei Shao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of gene editing technology CRISPR/Cas9 system in animal gene editing
by: Feng Fan, et al.
Published: (2018) -
CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017) -
CRISPR/Cas9-mediated genome editing in nonhuman primates
by: Yu Kang, et al.
Published: (2019) -
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
by: Nan Liu, et al.
Published: (2022) -
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
by: Nan Liu, et al.
Published: (2022)